Extended pancreatoduodenectomy with portal vein and inferior vena cava resection and reconstruction combined with sorafenib for hepatoid carcinoma of the pancreas:a strategy of superextended surgery combined with targeted therapy  

作　　者：Deling Wei Banghao Xu Hai Zhu Jilong Wang Zongrui Jin Weitao Chen Jianyong Zhang Zhujing Lan Keyu Huang Ling Zhang Tingting Lu Ni Fang Ya Guo Tao Peng Minhao Peng Zhang Wen 

机构地区：[1]Department of Hepatobiliary Surgery,the First Affiliated Hospital of Guangxi Medical University,Nanning,China [2]Department of Radiology,the First Affiliated Hospital of Guangxi Medical University,Nanning,China [3]Department of Ultrasound,the First Affiliated Hospital of Guangxi Medical University,Nanning,China [4]Department of Pathology,the First Affiliated Hospital of Guangxi Medical University,Nanning,China

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第4期637-640,I0027-I0030,共8页肝胆外科与营养（英文）

摘　　要：Hepatoid carcinoma of the pancreas(HCP)is an extremely rare pancreatic cancer resembling hepatocellular carcinoma,a type of liver cancer(1).Most reports have shown that it has an aggressive behavior and is associated with early metastasis.There is no standardized treatment for HCP due to its rarity,and the limited number of cases reported in the literature(2,3).However,treatment options for this type of rare cancer include surgery,chemotherapy,and radiation therapy,depending on the stage of the cancer.Nevertheless,the prognosis of HCP is poor.

关 键 词：chemotherapy METASTASIS treatment 

分 类 号：R735.7[医药卫生—肿瘤]